velusetrag dose 1
0093
Phase 2 small_molecule completed
Quick answer
velusetrag dose 1 for Gastroparesis is a Phase 2 program (small_molecule) at Theravance Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Theravance Biopharma
- Indication
- Gastroparesis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed